Literature DB >> 25687581

Molecular epidemiology of infectious bursal disease virus in Zambia.

Christopher J Kasanga1, Tsuyoshi Yamaguchi, Hetron M Munang'andu, Kenji Ohya, Hideto Fukushi.   

Abstract

Nucleotide sequences of the VP2 hypervariable region (VP2-HVR) of 10 infectious bursal disease viruses detected in indigenous and exotic chickens in Zambia from 2004 to 2005 were determined. Phylogenetic analysis showed that the viruses diverged into two genotypes and belonged to the African very virulent types (VV1 and VV2). In the phylogenetic tree, strains in one genotype clustered in a distinct group and were closely related to some strains isolated in western Africa (VV1), with nucleotide similarities of 95.7%- 96.5%. Strains in the other genotype were clustered within the eastern African VV type (VV2), with nucleotide similarities of 97.3%- 98.5%. Both genotypes were distributed in the southern parts of Zambia and had a unique conserved amino acid substitution at 300 (E→A) in addition to the putative virulence marker at positions 222(A), 242(I), 256(I), 294(I) and 299(S). These findings represent the first documentation of the existence of the African VV-IBDV variants in both indigenous and exotic chickens in Zambia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 25687581     DOI: 10.4102/jsava.v84i1.908

Source DB:  PubMed          Journal:  J S Afr Vet Assoc        ISSN: 1019-9128            Impact factor:   1.474


  2 in total

1.  Molecular characterization of field infectious bursal disease virus isolates from Nigeria.

Authors:  Ijeoma O Nwagbo; Ismaila Shittu; Chika I Nwosuh; George O Ezeifeka; Frederick J C Odibo; Linda O Michel; Daral J Jackwood
Journal:  Vet World       Date:  2016-12-15

2.  Prioritizing smallholder animal health needs in East Africa, West Africa, and South Asia using three approaches: Literature review, expert workshops, and practitioner surveys.

Authors:  Zoë Campbell; Paul Coleman; Andrea Guest; Peetambar Kushwaha; Thembinkosi Ramuthivheli; Tom Osebe; Brian Perry; Jeremy Salt
Journal:  Prev Vet Med       Date:  2021-01-27       Impact factor: 2.670

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.